Pneumocare

Erpent 5101

2 studies enrolling now · 3 studies all time

What they study most

COVID-19 SARS-CoV-2 Infection, Chronic Rhinosinusitis With Nasal Polyps (CRSwNP), Perennial Allergic Rhinitis (PAR)

Studies at this site

• A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP) — Recruiting now
• A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease — Recruiting now
• A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1) — Running, not enrolling